SOPHARMA AD hereby informs that from 23 October 2014 up to and including 29 October 2014 the Company bought 1 375 own shares representing 0.001% of the share capital of the Company, to the total value of 5389.9 BGN on the Bulgarian Stock Exchange, the average price per share was 3.92 BGN. The trading of treasury shares is pursuant to decision by the Annual General Meeting of Shareholders from 23 June 2010. The total number of treasury shares after these transactions is 5 106 052, representing 3.87% of the share capital of the Company.

Sopharma AD (the “Company”) announces that on 3 November 2014 the Company bought 500 000 shares from the capital of Medika AD. After this transaction, the share of Sopharma AD in the capital of Medika AD increased to 19, 22%.

Sopharma AD (the “Company”) announces that on 4 November 2014 the Company bought 400 010 shares from the capital of Medika AD. After this transaction, the share of Sopharma AD in the capital of Medika AD increased to 23.20%.

Sopharma AD (the “Company”) notifies that for October 2014 the Company recorded an increase of sales revenues of 4% compared to the same month of 2013, including 12% increase of domestic sales and 1% increase of export sales. During the past ten months Sopharma AD recorded a decrease of sales revenues of 4%, including 4% increase of domestic sales and 7% decrease of export sales compared to the same period of 2013

SOPHARMA AD hereby informs that from 30 October 2014 up to and including 05 November 2014 the Company bought 1 000 own shares representing 0.0008% of the share capital of the Company, to the total value of 3 900 BGN on the Bulgarian Stock Exchange, the average price per share was 3.90 BGN. The trading of treasury shares is pursuant to decision by the Annual General Meeting of Shareholders from 23 June 2010. The total number of treasury shares after these transactions is 5 107 052, representing 3.87% of the share capital of the Company.

Sopharma AD (the “Company”) notifies that on 7 November 2014 the Financial Supervision Commission approved the Contract for transformation through merger and two additional annexes to it, signed on 19 June 2014 between Sopharma AD, Sofia, UIC 831902088, hereinafter referred to as "Acquirer" and Bulgarian Rose – Sevtopolis AD, Kazanlak, UIC 123007916, hereinafter referred to as "Acquiree" in accordance with the requirements of art. 262d and following of the Commercial Act (CA).

SOPHARMA AD hereby informs that from 6 November 2014 up to and including 12 November 2014 the Company bought 2 100 own shares representing 0.0015% of the share capital of the Company, to the total value of 8 201.8 BGN on the Bulgarian Stock Exchange, the average price per share was 3.91 BGN. The trading of treasury shares is pursuant to decision by the Annual General Meeting of Shareholders from 23 June 2010. The total number of treasury shares after these transactions is 5 109 152, representing 3.87% of the share capital of the Company.

SOPHARMA AD hereby informs that from 13 November 2014 up to and including 19 November 2014 the Company bought 300 own shares representing 0.0002% of the share capital of the Company, to the total value of 1109.8 BGN on the Bulgarian Stock Exchange, the average price per share was 3.70 BGN. The trading of treasury shares is pursuant to decision by the Annual General Meeting of Shareholders from 23 June 2010. The total number of treasury shares after these transactions is 5 109 452, representing 3.87% of the share capital of the Company.

SOPHARMA AD hereby informs that from 20 November 2014 up to and including 26 November 2014 the Company bought 1 211 own shares representing 0.0009% of the share capital of the Company, to the total value of 4 479.49 BGN on the Bulgarian Stock Exchange, the average price per share was 3.70 BGN. The trading of treasury shares is pursuant to decision by the Annual General Meeting of Shareholders from 23 June 2010. The total number of treasury shares after these transactions is 5 110 663, representing 3.87% of the share capital of the Company.

SOPHARMA AD hereby informs that from 27 November 2014 up to and including 3 December 2014 the Company bought 2 180 own shares representing 0.0017% of the share capital of the Company, to the total value of 8 285.7 BGN on the Bulgarian Stock Exchange, the average price per share was 3.80 BGN. The trading of treasury shares is pursuant to decision by the Annual General Meeting of Shareholders from 23 June 2010. The total number of treasury shares after these transactions is 5 112 843, representing 3.87% of the share capital of the Company.